i4i Product Development Awards support the research and development of medical technologies in any area of existing or emerging clinical need. The expected output of i4i funding is an advanced or clinically validated prototype medical device, technology or intervention.
The objectives of i4i are to:
The lead organisation must be based in England. The following types of organisations are eligible for funding:
Specialist services or expertise may be brought into the team through consultancy or sub-contract arrangements. NHS Trust are considered an eligible collaboration.
Maximum duration of 3 years. There is no upper funding limit, but all costs must be sufficiently justified, and proposals must provide value for money.
The NIHR i4i programme is a translational funding scheme which advances healthcare technologies and interventions for increased patient benefit in areas of existing or emerging clinical need. It supports research and development of medical devices, active implantable devices and in vitro diagnostic devices.
Funded activities include the following: